Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2017 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 500 | $70.79 | $35,395.00 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 5 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,902,492 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $70.75 to $70.85, inclusive. F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| December 04, 2017 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 6,181 | $70.44 | $435,389.64 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,902,992 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $69.75 to $70.725, inclusive. F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| December 01, 2017 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 192 | $71.75 | $13,776.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,909,173 Read SEC document |
| December 01, 2017 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 11,644 | $70.49 | $820,785.56 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,909,365 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F3 · price: Weighted average price. Price range in multiple transactions was $69.95 to $70.85, inclusive. Read SEC document |
| December 01, 2017 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 600 | $69.21 | $41,526.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,921,009 F1 · price: Weighted average price. Price range in multiple transactions was $68.95 to $69.60, inclusive. F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| December 01, 2017 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 192 | $71.75 | $13,776.00 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,909,173 F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| December 01, 2017 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 11,644 | $70.49 | $820,785.56 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,909,365 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F3 · price: Weighted average price. Price range in multiple transactions was $69.95 to $70.85, inclusive. F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| December 01, 2017 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 600 | $69.21 | $41,526.00 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,921,009 F1 · price: Weighted average price. Price range in multiple transactions was $68.95 to $69.60, inclusive. F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 19:40 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
Exercise / conversionStock-Settles Stock appreciation Right · Derivative | 30,000 | $0.00 Strike: $65.48 | $0.00 |
DisclosureSEC source: 0001179110-17-014761 · edgar.xml · derivative · entry 3 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 30,000 shares Expires 2022-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 19:40 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
SaleCommon Stock | 2,716 | $72.00 | $195,552.00 |
DisclosureSEC source: 0001179110-17-014761 · edgar.xml · nonDerivative · entry 2 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 19:40 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
Exercise / conversionCommon Stock | 2,716 | $65.48 | $177,843.68 |
DisclosureSEC source: 0001179110-17-014761 · edgar.xml · nonDerivative · entry 1 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 21:30 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 45,216 | $66.44 | $3,004,146.52 |
DisclosureSEC source: 0001179110-17-014625 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,694,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.772, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 21:30 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 45,216 | $66.44 | $3,004,146.52 |
DisclosureSEC source: 0001179110-17-014624 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,694,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.772, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 21, 2017 Filed Nov 21, 2017 22:47 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 117,270 | $66.53 | $7,801,797.20 |
DisclosureSEC source: 0001179110-17-014441 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,739,269 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $66.00 to $67.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 21, 2017 Filed Nov 21, 2017 22:47 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 117,270 | $66.53 | $7,801,797.20 |
DisclosureSEC source: 0001179110-17-014440 · edgar.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,739,269 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $66.00 to $67.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 20, 2017 Filed Nov 21, 2017 22:47 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 39,751 | $66.11 | $2,628,053.89 |
DisclosureSEC source: 0001179110-17-014441 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,856,539 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.275, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 20, 2017 Filed Nov 21, 2017 22:47 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 39,751 | $66.11 | $2,628,053.89 |
DisclosureSEC source: 0001179110-17-014440 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,856,539 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.275, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 22:47 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 7,895 | $66.03 | $521,277.64 |
DisclosureSEC source: 0001179110-17-014441 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,896,290 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 22:47 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 7,895 | $66.03 | $521,277.64 |
DisclosureSEC source: 0001179110-17-014440 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,896,290 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 16, 2017 Filed Nov 16, 2017 22:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 80,172 | $66.06 | $5,295,857.67 |
DisclosureSEC source: 0001179110-17-014213 · edgar.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,904,185 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.3875, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 16, 2017 Filed Nov 16, 2017 22:20 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 80,172 | $66.06 | $5,295,857.67 |
DisclosureSEC source: 0001179110-17-014212 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,904,185 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.3875, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 22:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 11,835 | $66.07 | $781,959.75 |
DisclosureSEC source: 0001179110-17-014213 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,984,357 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.05 to $66.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 22:20 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 11,835 | $66.07 | $781,959.75 |
DisclosureSEC source: 0001179110-17-014212 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,984,357 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.05 to $66.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 22:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 9,922 | $66.00 | $654,852.00 |
DisclosureSEC source: 0001179110-17-014213 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,996,192 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 22:20 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 9,922 | $66.00 | $654,852.00 |
DisclosureSEC source: 0001179110-17-014212 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,996,192 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 13, 2017 Filed Nov 13, 2017 21:45 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 5,304 | $66.01 | $350,125.53 |
DisclosureSEC source: 0001179110-17-014031 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,006,114 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 13, 2017 Filed Nov 13, 2017 21:44 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 5,304 | $66.01 | $350,125.53 |
DisclosureSEC source: 0001179110-17-014030 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,006,114 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:45 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 1,985 | $66.01 | $131,033.82 |
DisclosureSEC source: 0001179110-17-014031 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,011,418 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:44 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 1,985 | $66.01 | $131,033.82 |
DisclosureSEC source: 0001179110-17-014030 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,011,418 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 02, 2017 Filed Nov 2, 2017 22:52 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 22,893 | $65.02 | $1,488,605.88 |
DisclosureSEC source: 0001179110-17-013678 · edgar.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,013,403 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F5 · price: Weighted average price. Price range in multiple transactions was $64.40 to $65.40, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 02, 2017 Filed Nov 2, 2017 22:52 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 22,893 | $65.02 | $1,488,605.88 |
DisclosureSEC source: 0001179110-17-013677 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,013,403 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F5 · price: Weighted average price. Price range in multiple transactions was $64.40 to $65.40, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 01, 2017 Filed Nov 2, 2017 22:52 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 17,107 | $65.42 | $1,119,074.93 |
DisclosureSEC source: 0001179110-17-013678 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,036,296 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $64.85 to $65.85, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| November 01, 2017 Filed Nov 2, 2017 22:52 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 17,107 | $65.42 | $1,119,074.93 |
DisclosureSEC source: 0001179110-17-013677 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,036,296 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $64.85 to $65.85, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 22:52 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 3,292 | $66.01 | $217,301.96 |
DisclosureSEC source: 0001179110-17-013678 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,053,403 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 22:52 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 3,292 | $66.01 | $217,301.96 |
DisclosureSEC source: 0001179110-17-013677 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,053,403 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.00 to $66.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 30, 2017 Filed Oct 30, 2017 20:54 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 21,209 | $66.11 | $1,402,033.67 |
DisclosureSEC source: 0001179110-17-013534 · edgar.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,056,695 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $66.00 to $67.025, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 30, 2017 Filed Oct 30, 2017 20:54 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 21,209 | $66.11 | $1,402,033.67 |
DisclosureSEC source: 0001179110-17-013533 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,056,695 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $66.00 to $67.025, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 27, 2017 Filed Oct 30, 2017 20:54 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 11,363 | $67.26 | $764,240.15 |
DisclosureSEC source: 0001179110-17-013534 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,077,904 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $67.25 to $67.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 27, 2017 Filed Oct 30, 2017 20:54 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 11,363 | $67.26 | $764,240.15 |
DisclosureSEC source: 0001179110-17-013533 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,077,904 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $67.25 to $67.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 20:54 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 60,871 | $67.39 | $4,101,895.82 |
DisclosureSEC source: 0001179110-17-013534 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,089,267 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.50 to $68.275, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 20:54 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 60,871 | $67.39 | $4,101,895.82 |
DisclosureSEC source: 0001179110-17-013533 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,089,267 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $66.50 to $68.275, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 17:01 UTC |
AUCIAUX ROBERTDirector
|
Exercise / conversionStock-Settled Stock Appreciation Rights · Derivative | 16,000 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-013517 · edgar.xml · derivative · entry 3 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2018-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 17:01 UTC |
AUCIAUX ROBERTDirector
|
Tax withholdingCommon Stock | 2,785 | $68.65 | $191,190.25 |
DisclosureSEC source: 0001179110-17-013517 · edgar.xml · nonDerivative · entry 2 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 17:01 UTC |
AUCIAUX ROBERTDirector
|
Exercise / conversionCommon Stock | 9,285 | $28.81 | $267,500.85 |
DisclosureSEC source: 0001179110-17-013517 · edgar.xml · nonDerivative · entry 1 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights in Table-II. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 17:02 UTC |
FULLER GILBERT ADirector
|
Exercise / conversionStock-Settled Stock Appreciation Rights · Derivative | 3,000 | $28.81 Strike: $28.81 | $86,430.00 |
DisclosureSEC source: 0001179110-17-013518 · edgar.xml · derivative · entry 3 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2018-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 17:02 UTC |
FULLER GILBERT ADirector
|
SaleCommon Stock | 1,710 | $67.01 | $114,590.01 |
DisclosureSEC source: 0001179110-17-013518 · edgar.xml · nonDerivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price. Price range in multiple transactions was $67.00 to $67.05, inclusive. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 17:02 UTC |
FULLER GILBERT ADirector
|
Exercise / conversionCommon Stock | 1,710 | $28.81 | $49,265.10 |
DisclosureSEC source: 0001179110-17-013518 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 21:34 UTC |
Brown JimPresident & COO
|
GrantRestricted Stock Units · Derivative | 4,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013442 · edgar.xml · derivative · entry 1 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,513 Underlying: Common Stock · 4,020 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:46 UTC | GrantRestricted Stock Units · Derivative | 2,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013437 · edgar.xml · derivative · entry 1 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,236 Underlying: Common Stock · 2,691 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
|
| October 23, 2017 Filed Oct 25, 2017 20:45 UTC |
Macuga Daniel A.Chief Communications Officer
|
GrantRestricted Stock Units · Derivative | 2,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013436 · edgar.xml · derivative · entry 1 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,047 Underlying: Common Stock · 2,555 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.